drugset / Trial / NCT00326807

Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling

NCT00326807

RandomizedDouble-blindTreatment

Summary

This study assessed whether naltrexone, an opioid antagonist, might be effective in reducing excessive gambling behavior in people who also drink heavily. The efficacy of naltrexone was evaluated in a randomized, double-blind, placebo-controlled trial. Fifty-two subjects who had significant problems with both gambling and alcohol received 11 weeks of either naltrexone or placebo.

Timeline

Start
2001-06
Primary completion
Completion
2004-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule

Indications